Gsa Capital Partners LLP Applied Genetic Technologies Corp Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $1.09 Million - $1.7 Million	-583,510 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.01 - $4.12 $1.38 Million - $1.89 Million	458,420 Added 366.47%	583,510 $1.76 Million
Q2 2021 Aug 05, 2021	BUY	$3.62 - $5.23 $452,825 - $654,220	125,090 New	125,090 $489,000
Q1 2021 May 10, 2021	SELL	$3.94 - $8.19 $59,545 - $123,775	-15,113 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$3.99 - $5.7 $60,300 - $86,144	15,113 New	15,113 $62,000
Q1 2018 May 11, 2018	SELL	$3.65 - $5.2 $244,185 - $347,880	-66,900 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$3.4 - $4.15 $298,520 - $364,370	-87,800 Reduced 56.76%	66,900 $241,000
Q3 2017 Nov 20, 2017	BUY	$3.55 - $5.25 $549,185 - $812,175	154,700	154,700 $611,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.